News | Lung Imaging | December 23, 2015

Low-dose CT Finds Early Lung Cancer in Longtime Smokers

Study finds CT able to detect significantly smaller cancers than traditional chest X-ray

low-dose CT, lung cancer screening, longtime smokers, Wake Forest Baptist Medical Center, clinical study

December 23, 2015 — A new national study involving 53,000 patients and 11 institutions compared computed tomography (CT) screens with chest X-rays to determine whether lung cancer in longtime smokers can be caught before it is too late.

“For some patients, the perception is that lung cancer is terminal, but that’s not always the case,” said Christina Bellinger, M.D., a pulmonologist at Wake Forest Baptist Medical Center in Winston-Salem, North Carolina. “Lung cancer screening has proven effective in detecting lung cancer when it’s still in its treatable stage.”

The screening is done with low-dose CT scans that can detect tumors as small as 3/64 of an inch. The process is recommended by the U.S. Preventive Services Task Force, American Cancer Society and numerous other organizations for people age 55 and over with no symptoms of lung cancer who have smoked the equivalent of one pack of cigarettes a day for 30 years and who still smoke or have quit within the past 15 years.

Study results found that the scanning reduced lung cancer mortality by 20 percent in this high-risk population. The results were so conclusive, in fact, that the study was concluded early.

In light of those findings, Medicare and Medicaid earlier this year began paying for the screening for patients who meet their eligibility criteria, and many private insurance companies are also doing so.

“CT scans are the only way to detect lung cancer early,” Bellinger said. “All longtime smokers should discuss screening with their physicians.”

While cigarette smoking rates in the United States have steadily decreased over the past 50 years – from 42 percent among adults in 1965 to around 15 percent today, according to the federal Centers for Disease Control and Prevention – lung cancer remains the leading cause of cancer deaths in both men and women. In 2012, the most recent year for which statistics are available, 210,828 Americans were diagnosed with lung cancer and 157,423 died from the disease.

Not smoking and avoiding second-hand smoke are indisputably the best ways to reduce the risk of lung cancer, and CT screening is not a substitute for quitting smoking. But it is a significant advance in the fight against the disease: It is estimated that the widespread use of CT scans could prevent as many as 12,000 lung cancer-related deaths among the nearly 9 million over-55 smokers and former smokers in the United States.

Chest X-rays, for decades the most commonly employed method of screening for lung cancer, have never proved effective in reducing mortality rates because they generally reveal only larger tumors that are too far advanced to be treated with surgery or radiation therapy.

“CT scanning provides detailed, cross-sectional pictures of the lungs that let us see very small nodules very clearly,” said Michael Holbert, M.D., a cardiothoracic radiologist at Wake Forest Baptist. “This allows us to better differentiate between suspicious, potentially cancerous abnormalities and those that aren’t, and also to follow changes in them over time.”

For the process to be effective in detecting lung cancer at an early stage, patients need to have a scan done annually through at least age 74.

Statistics show that CT scans of 100 people fitting the age and smoking-history profile will detect nodules on the lungs of between 15 and 20 of them. Among these, just one will prove to be malignant. And in 90 percent of these cases, the cancer is at a treatable stage.

The screening itself is quick – the scan is done while the patient holds his or her breath for five to 10 seconds – and noninvasive – no contrast dye is administered and no IV is required. And the radiation dose is extremely low, less than one-fifth that of a routine chest CT scan.

The process does involve some risks, including false positives (indications of cancer when no malignancy is present). And the screening has some limitations: CT scans can not detect all cases of lung cancer, and they may show tumors that are too far advanced to be treated. The scans also may reveal signs of bronchitis, emphysema and other smoking-related conditions at various stages.

But to older longtime smokers, the proven benefits of CT screening should outweigh any negatives.

“Even if patients are still smoking, or if they’re afraid of what a CT scan might show, it’s important that they undergo lung cancer screening as part of their health maintenance,” Bellinger said.

“We have solid scientific data that CT lung cancer screening can save lives,” Holbert said. “It’s a good deal.”

For more information: www.wakehealth.edu

Related Content

Treating lung cancer patients with proton therapy may help reduce the risk of radiation-induced heart diseases, suggests a new study from Penn Medicine. In a retrospective trial of more than 200 patients, mini-strokes were significantly less common among patients who underwent proton therapy versus conventional photon-based radiation therapy. Proton therapy patients also experienced fewer heart attacks.
News | Proton Therapy | October 25, 2020
October 25, 2020 — Treating lung cancer patients with prot...
AI-powered premium large bore CT scanner offers industry’s largest bore and widest field-of-view
News | Computed Tomography (CT) | October 24, 2020
October 24, 2020 — An estimated 1.8 million new cancer cases will be diagnosed in the U.S.
An example of a HeartFlow FFR-CT image showing the blood flow through what looked like a significant blockage on CT angiography alone, actually was not flow-limiting based on computational fluid dynamics. Use of the technology was supposed to reduce the number of diagnostic catheterizations in the FORECAST trial, but the costs of FFR-CT were not offset enough to show cost savings.

An example of a HeartFlow FFR-CT image showing the blood flow through what looked like a significant blockage on CT angiography alone, actually was not flow-limiting based on computational fluid dynamics. Use of the technology was supposed to reduce the number of diagnostic catheterizations in the FORECAST trial, but the costs of FFR-CT were not offset enough to show cost savings.

Feature | CT Angiography (CTA) | October 23, 2020
October 22, 2020 – In the FORECAST randomized clinical trial, the use of ...
This illustration show the complexity of the data obtained from one single patient with moderate/severe traumatic brain injury. Different imaging approaches and techniques have their own unique sensitivity in assessing different aspects of neuroanatomy and neuropathology. What can be seen on images also changes with time since injury. Data from comprehensive clinical and functional assessments using a range of other tools is also important for evaluating patient outcome. Through data harmonization and large

This illustration show the complexity of the data obtained from one single patient with moderate/severe traumatic brain injury. Different imaging approaches and techniques have their own unique sensitivity in assessing different aspects of neuroanatomy and neuropathology. What can be seen on images also changes with time since injury. Data from comprehensive clinical and functional assessments using a range of other tools is also important for evaluating patient outcome. Through data harmonization and large-scale analyses of data combined across multiple research sites, the ENIGMA Brain Injury will develop and test methods and procedures for making sense of the complexity in this data. Images courtesy of Olsen et al., Brain Imaging and Behavior, 2020

News | Magnetic Resonance Imaging (MRI) | October 23, 2020
October 23, 2020 — Trau...
A, Initial conventional axial CT image shows no noticeable lung damage (within red box) in right upper lobe. B, Electron density spectral CT image obtained at same time as image in A shows lesions (within red box) in right upper lobe. C, Follow-up conventional axial chest CT image obtained 5 days after images in A and B confirm presence of lesions (within red box) in right upper lobe.

A, Initial conventional axial CT image shows no noticeable lung damage (within red box) in right upper lobe. B, Electron density spectral CT image obtained at same time as image in A shows lesions (within red box) in right upper lobe. C, Follow-up conventional axial chest CT image obtained 5 days after images in A and B confirm presence of lesions (within red box) in right upper lobe. Image courtesy of the American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Coronavirus (COVID-19) | October 22, 2020
October 22, 2020 — According to an open-...
The fMRI hyperscanning environment.

(A) The fMRI hyperscanning environment. The clinician (1) and patient (2) were positioned in two different 3T MRI scanners. An audio-video link enabled online communication between the two scanners (3), and video images were used to extract frame-by-frame facial expression metrics. During simultaneous acquisition of blood oxygen level–dependent (BOLD)–fMRI data, the clinician used a button box (4) to apply electroacupuncture (EA) treatment (real/sham, double-blind) to the patient (5) to alleviate evoked pressure pain to the leg (6; Hokanson cuff inflation). Pain and affect related to the treatment were rated after each trial. (B) Study overview. After an initial behavioral visit, each individual participated in a Clinical-Interaction (hyperscan preceded by a clinical intake) and No-Interaction condition (hyperscan without a preceding intake), in a counterbalanced order, with two different partners. (C) Experimental protocol. Each hyperscan was composed of 12 repeated trials (four verum EA, four sham EA, and four no treatment) in a pseudo-randomized order. After a resting period (far left), both participants were shown a visual cue to indicate whether the next pain stimulus would be treated (green frame) or not treated (red frame) by the clinician. These cues prompted clinicians prepare to either apply or not apply treatment while evoking corresponding anticipation for the patient. Following the anticipation cue, moderately painful pressure pain was applied to the patient’s left leg, while the clinician applied or did not apply treatment, respectively. After another resting period, participants rated pain (patients), vicarious pain (clinicians), and affect (both) using a visual analog scale (VAS).

News | Clinical Trials | October 22, 2020
October 22, 2020 — The potential impact of the patient-clinician relationship on a patient's response to treatment is
Lesion was originally reported as indeterminate enhancing mass, and outside report recommended biopsy. Classic features of benign hemangioma are shown. Error was attributed to faulty reasoning. A, Axial MR image obtained 5 minutes after contrast agent administration shows peripheral nodular discontinuous enhancement. B, Axial MR image obtained 10 minutes after contrast agent administration shows centripetal progression of enhancement (arrow). C, Axial fast imaging employing steady-state acquisition (FIESTA)

Lesion was originally reported as indeterminate enhancing mass, and outside report recommended biopsy. Classic features of benign hemangioma are shown. Error was attributed to faulty reasoning. A, Axial MR image obtained 5 minutes after contrast agent administration shows peripheral nodular discontinuous enhancement. B, Axial MR image obtained 10 minutes after contrast agent administration shows centripetal progression of enhancement (arrow). C, Axial fast imaging employing steady-state acquisition (FIESTA) MR image shows lesion is homogeneously hyperintense compared with liver parenchyma. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Magnetic Resonance Imaging (MRI) | October 21, 2020
October 21, 2020 — According to an artic...
According to an inquest, a man with a heart disorder and chest pain died two days after a doctor viewed the wrong scan and sent him home
News | Computed Tomography (CT) | October 21, 2020
October 21, 2020 — The BBC News
Rensselaer, First-Imaging, and GE Global researchers develop a deep neural network to perform nearly as well as more complex dual-energy CT imaging technology
News | Computed Tomography (CT) | October 20, 2020
October 20, 2020 — Bioimaging technologies are the eyes that allow doctors to see inside the body in order to diagnos